&w=3840&q=100)
From cancer detection to treatment, how AI is transforming health care
Shelley Singh New Delhi
Listen to This Article
In early 2024, Marly Garnreiter, a 27-year-old French woman, began experiencing persistent night sweats and itchy skin. Her doctors dismissed it as stress. Her blood report came back normal. Out of curiosity, she asked ChatGPT about it. The artificial intelligence (AI) chatbot suggested she might have blood cancer. Nearly a year later, in April 2025, doctors confirmed she had Hodgkin's lymphoma, a cancer that affects the lymphatic system.
Stories like Garnreiter's are making headlines repeatedly: AI catching what humans miss.
While anecdotal, they point to a shift underway in health care — one where AI doesn't replace doctors but sharpens
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
Old fossil-fuel plants are becoming green-energy hubs
FOR MORE than a decade the Tamaya power station in the Atacama desert in northern Chile powered its local region using diesel. Today a shimmering array of solar panels stands in place of the dirty generator. Engie, the French utility that owns the power station, converted it into a solar-energy and battery-storage plant earlier this year. Juan Villavicencio, the company's boss in Chile, describes the site as a place where 'the past and future of energy infrastructure meet'. Others share his vision. Developers, governments, startups and utilities around the world are turning former fossil-fuel power stations, and old oil and gas wells, into renewable-energy plants and testbeds for green technology. This way the relics of the fossil-fuel era will be put to good use. 'It makes no sense to just throw [them] away,' says Arash Dahi Taleghani, an engineer at Pennsylvania State University. According to the Carnegie Endowment for International Peace (CEIP), a think-tank, there are around 170 ongoing or completed projects to transform old fossil-fuel power stations into renewable-energy plants. The trend is spreading across the world, says Milo McBride, a research fellow at the CEIP. China, for instance, recently announced its first project—parts of the Baotou coal power plant in Inner Mongolia will be turned over to wind and solar generation, as well as battery storage. The sites offer connections to the grid, which can save developers looking to get renewable-energy projects online lengthy delays. Researchers led by Umed Paliwal at the University of Berkeley, California, have found that 1,000 gigawatts (GW) could be added to the American grid capacity if renewable-energy projects were hooked up to existing fossil-fuel plants and probably more if retired sites were exploited. According to the International Energy Agency, an official body, renewable-energy projects that could generate about 3,000 gigawatts (GW) worldwide are waiting for a grid connection. Repurposing could help resolve that issue. Old oil and gas wells could also be attractive. A study by Mary Kang at McGill University found that most idle wells in America and Canada might be suitable for at least some kind of geothermal-energy production. Benjamin Burke, the boss of Gradient Geothermal, an American startup, says that the cost of drilling a new well deep enough to host the technology can be prohibitive. Using old wells is comparably cheap, even if their location and build are more suited to oil and gas production. Yet repurposing facilities presents challenges. Some former fossil-fuel sites are too compact to host vast wind and solar farms. Many will not be able to generate as much power as they did before. Around 35% of projects in CEIP's database partly or wholly deploy technologies that produce carbon emissions, such as bioenergy (burning organic matter to produce heat) and hydrogen blending (mixing green hydrogen with natural gas). What's more, regulatory roadblocks may limit progress. Alexandra Klass and Hannah Wiseman, legal scholars at the University of Michigan and Penn State Law, say that obtaining permits to develop brownfield sites in America is often costlier than getting permits for pristine land. And, although some support may exist at state level, President Donald Trump has axed federal renewable-energy tax credits that reduced the cost of repurposing. Nevertheless, demand for more ambitious green projects should continue to grow. Over the next 15 years, 300GW of coal power capacity is set to be retired around the world, and the cost of producing renewable energy could fall by up to 49%, according to BloombergNEF, a data provider. Other countries have created a more nurturing environment than America. Keith Hirsche, founder of RenuWell Energy Solutions, a renewable-energy company, says Canadian authorities fast-tracked his firm's permit to build because it was on a brownfield site. In Indonesia the national energy-transition strategy includes plans to transform old fossil-fuel assets. Many more plants will soon be pumping out green power.
Hindustan Times
13 hours ago
- Hindustan Times
Fadnavis inaugurates AI institute
Pune: Maharashtra Chief Minister Devendra Fadnavis inaugurated Symbiosis Artificial Intelligence Institute (SAII) in the city on Wednesday. Devandra Fadnavis (PTI) 'AI can predict human emotions, but it cannot feel them. Only humans are capable of truly experiencing emotions,' he said during the event. Symbiosis founder president SB Mujumdar, pro-chancellor Vidya Yeravdekar, vice-chancellor Ramakrishnan Raman, and director Loveleen Gaur were present during the event. 'We embraced the computer revolution and excelled in the digital world. Now, AI, quantum computing, and semiconductors will shape every stage of our lives,' said Fadnavis. The state, he added, is introducing AI literacy programmes, AI-powered agricultural tools for crop protection, and smart traffic management systems in partnership with Google. Chatbots have already been deployed across government departments to provide citizens with instant responses. 'Every new technology has two sides. Instead of fearing it, we must learn to master it,' said Fadnavis. At the event, Fadnavis also launched an AI-powered multilingual virtual assistant developed by Symbiosis alumni. It currently supports Hindi, English, Marathi, Arabic, and French.
The Hindu
14 hours ago
- The Hindu
A bistable gene in a deadly bacterium offers a clue to beating it
The French biochemist Jacques Monod (1910-1976), who won a Nobel Prize in 1965 for discovering how cells regulate the expression of genes, famously said, 'What is true for Escherichia coli is true for the elephant.' He meant the same fundamental mechanisms of molecular biology, such as protein synthesis, DNA replication, and cellular metabolism, are shared by both bacteria and elephants. In his comment, Monod was taking a bird's-eye view of biology. If you zoomed in enough, two bacterial cells with identical genomes — and even from the same colony — can be quite different from each other. One cell might express a particular gene at a high level while the other might express it at a low level or not at all. Each bacterium goes on to transmit its expression level to its offspring in a process called epigenetic inheritance. Such variations among otherwise identical cells and organisms is called bistability. Bistability might be a survival strategy that single-celled organisms use to adapt to fluctuating environmental conditions. Now, a team of researchers, led by scientists from the Helmholtz Centre for Infection Research in Germany, has reported that a gene in the bacterium Pseudomonas aeruginosa shows bistable expression. This is important because P. aeruginosa is an opportunistic and deadly pathogen. Most burn victims succumb to secondary P. aeruginosa infections. It is a major cause of keratitis, an eye infection, and also infects urinary catheters. Hospital infections of P. aeruginosa are notoriously resistant to antibiotics. Medical researchers and doctors are keen to understand what makes the bacterium so deadly — and the new study opens a door towards this goal. The researchers have reported that the differential expression of the glpD gene in individual cells of P. aeruginosa was associated with differences in the bacterium's ability to cause disease, i.e. its pathogenicity properties. The findings were reported in Proceedings of the National Academy of Sciences. Tracking gene expression The genome of P. aeruginosa contains nearly 6,000 genes. When a gene is expressed, the cell makes corresponding RNA. These RNA serve as transcripts. Think of them as the gene's working copies. The cell loads these RNA onto protein-making factories called ribosomes. There the information from the RNA is used to stitch amino acids together in different sequences to make the protein corresponding to that gene. Many genes produce relatively few transcripts. Let's call them low expression genes (LEGs). The high expression genes (HEGs) on the other hand produce many more transcripts — in some instances 100x to 10,000x more. In general, there is less variation in transcript numbers when an HEG is expressed than when an LEG is expressed. While an LEG in one cell might express one transcript, in another cell it might express 30, so this is a range of 30x. But for HEGs, a 30x range is highly unlikely. In the new study, the researchers analysed over 300 P. aeruginosa strains for all the transcripts that they made from their genes. They found that although the glpD gene was an HEG, the variation in its transcript counts P. aeruginosa cells made was way more than for the other HEGs. The finding hinted that the glpD gene might be an HEG in some cells and an LEG in others. To explore this possibility, the team fused the DNA segment that regulated the expression of the glpD gene with a gene that makes the green fluorescent protein (GFP). Whenever the glpD gene was expressed, the cell would also make the GFP protein, which glows under light. This way, the researchers had a small, green light-bulb that lit up when the glpD gene was expressed. The team also used a more short-lived variant of GFP to make the signal more accurately reflect the gene's real-time expression. The fickle gene Only a small fraction of cells with the fusion gene lit up and maintained their 'on' state over an extended period of time. More interestingly, when a cell that had already lit up divided into two, one of the daughter cells also lit up but the other didn't. In some lineages, the team found that the 'on' ability was passed down to up to five generations. In lineages that descended from a single cell that didn't light up, i.e. was 'off', about 5-6% of the daughter cells randomly switched to 'on'. And in half of these cases, the 'on' state was short-lived. In the other half, it persisted as if the cell had descended from an 'on' ancestor. Finally, more cells were 'on' when glycerol was present. This was expected since P. aeruginosa bacteria use the glpD gene to make use of glycerol. The moth larva test The larvae of the greater wax moth (Galleria mellonella) are parasites of honeycombs. Scientists use the larvae as a model to study how bacterial infections develop and spread. In the new study as well, the researchers infected greater wax moth larvae with P. aeruginosa bacteria — but before they did, they removed the glpD gene first. The researchers found that these P. aeruginosa bacteria had a significantly reduced ability to kill the larvae compared to bacteria containing the intact gene. This was a sign that the expression of the glpD gene was associated with the bacteria's ability to infect. The researchers hypothesised that the interaction of P. aeruginosa with the cells in the bodies of the mammals (including humans) it infects might also be associated with higher glpD expression. To test this, the team cultured mouse immune cells and infected them with P. aeruginosa bacteria containing the GFP fusion gene. Team members found that the bacteria that came in contact with macrophage cells of the mouse immune system fluoresced more brightly, meaning glpD was being expressed more. Playing it safe The variability in the expression levels of the glpD expression was evident even in small clusters of around 10-50 cells. Given that cells that produced more glpD transcripts were better at setting infections in motion suggested that an infection can be initiated by even a small group. As the researchers wrote in their paper, 'varying levels of glpD expression … might be a strategy … for the success of P. aeruginosa as an opportunistic pathogen'. Axiomatically, a drug targeting this variation could prevent P. aeruginosa from being the scourge it currently is in hospitals. D.P. Kasbekar is a retired scientist.
